0001745285-20-000015.txt : 20200617
0001745285-20-000015.hdr.sgml : 20200617
20200617172636
ACCESSION NUMBER: 0001745285-20-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200616
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Corvese Brian
CENTRAL INDEX KEY: 0001393207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 20970624
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC.
STREET 2: 162 FIFTH AVENUE, SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-16
0
0001098972
AGENUS INC
AGEN
0001393207
Corvese Brian
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Restricted Stock Unit
2020-06-16
4
A
0
22471
0
A
2021-06-16
Common Stock
22471
49589
D
Stock Option (Right to buy)
3.56
2020-06-16
4
A
0
2500
0
A
2021-06-16
2030-06-16
Common Stock
2500
2500
D
(1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.
Includes 27,118 Restricted Stock Units that are scheduled to vest on June 19, 2020.
Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021.
/s/Evan D. Kearns, as Attorney-in-Fact for Brian Corvese
2020-06-17